Patent JPS6021028A successfully refreshed from Google Patents.
Patent JPS6174901A successfully refreshed from Google Patents.
Patent US5663064A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5663064A Expired / Lapsed US ⏱️ 0.0 years remaining

Ribozymes with RNA protein binding site

Assignee: University of Vermont
•
Filing: 1995-01-13
•
Granted: 1997-09-02
•
Expires: 2015-01-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Ribozyme having a ligand binding site formed as a double-stranded RNA and a single-stranded loop, the ribozyme having enzymatic activity to cleave and/or ligate itself or a separate RNA molecule.

Inventors

  • 👤 John M. Burke
  • 👤 Bruno Sargueil

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-10 02:05
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C12N15/113; A; A61; A61K; A61K38/00; C12N2310/00; C12N2310/10; C12N2310/12; C12N2310/122; C12N2310/30; C12N2310/35; C12N2310/351; C12N2310/3513

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 65 words
An enzymatic RNA molecule comprising: a protein binding site formed as a double-stranded RNA and a single-stranded loop, wherein said enzymatic RNA molecule is capable of specifically cleaving a separate RNA molecule, wherein said site is selected from a group shown in FIGS. 2 and 12-17 (SEQ. ID. Nos. 4, 10-16 and 18-28) inclusive, and wherein said enzymatic nucleic acid is in a hairpin motif.
Claim 2
Dependent Claim 65 words
An enzymatic RNA molecule comprising: a protein binding site formed as a double-stranded RNA and a single-stranded loop, wherein said enzymatic RNA molecule is capable of specifically cleaving a separate RNA molecule, wherein said site is selected from a group shown in FIGS. 2 and 12-17 (SEQ. ID. Nos. 4, 10-16 and 18-28) inclusive, and wherein said enzymatic nucleic acid is in a hairpin motif.
Claim 3
Dependent Claim 24 words
The enzymatic RNA molecule of claim 1 or 4 wherein a protein is bound to said protein binding site in said enzymatic RNA molecule.
Claim 4
Dependent Claim 29 words
The enzymatic RNA molecule of claim 1 or 4 wherein the said protein binding site is adjacent to the 3' or the 5' end of said enzymatic RNA molecule.
Claim 5
Dependent Claim 64 words
An enzymatic RNA molecule comprising: a protein binding site formed as a double-stranded RNA and a single-stranded loop, wherein said enzymatic RNA molecule is capable of specifically ligating separate RNA molecules, wherein said site is selected from a group shown in FIGS. 2 and 12-17 (SEQ ID Nos. 4, 10-16 and 18-28) inclusive, and wherein said enzymatic nucleic acid is in a hairpin motif.
Claim 6
Dependent Claim 64 words
An enzymatic RNA molecule comprising: a protein binding site formed as a double-stranded RNA and a single-stranded loop, wherein said enzymatic RNA molecule is capable of specifically ligating separate RNA molecules, wherein said site is selected from a group shown in FIGS. 2 and 12-17 (SEQ ID Nos. 4, 10-16 and 18-28) inclusive, and wherein said enzymatic nucleic acid is in a hairpin motif.
Claim 7
Dependent Claim 20 words
The enzymatic RNA molecule of claim 1 or 4, wherein said protein binding site is capable of binding R17 protein.
Claim 8
Dependent Claim 24 words
The enzymatic RNA molecule of claim 1 or 4, wherein said protein binding site is capable of binding human immunodeficiency virus encoded TAT protein.
Claim 9
Dependent Claim 24 words
The enzymatic RNA molecule of claim 1 or 4, wherein said protein binding site is capable of binding human immunodeficiency virus encoded Rev protein.
Claim 10
Dependent Claim 24 words
The enzymatic RNA molecule of claim 1 or 4, wherein said protein binding site is capable of binding mammalian iron response element binding protein.
Claim 11
Dependent Claim 23 words
The enzymatic RNA molecule of claim 1 or 4, wherein said protein binding site is capable of binding mammalian vascular endothelial growth factor.
Claim 12
Dependent Claim 15 words
A mammalian cell in vitro including the enzymatic RNA molecule of claim 1 or 4.
Claim 13
Dependent Claim 32 words
An expression vector comprising nucleic acid encoding the enzymatic RNA molecule of claim 1 or 4, in a manner which allows expression of that enzymatic RNA molecule within a cell in vitro.
Claim 14
Dependent Claim 13 words
A mammalian cell in vitro including an the expression vector of claim 11.
Claim 15
Independent Claim 33 words
A method for increasing the activity of a an enzymatic RNA molecule in a hairpin motif by including a RNA protein binding site in the helix 4 region of said enzymatic RNA molecule.
Claim 16
Independent Claim 33 words
A method for increasing the activity of a an enzymatic RNA molecule in a hairpin motif by including a RNA protein binding site in the helix 4 region of said enzymatic RNA molecule.
Claim 17
Independent Claim 20 words
A method for decreasing the activity of a hairpin ribozyme by including a RNA protein binding site in helix 4.
Claim 18
Independent Claim 20 words
A method for decreasing the activity of a hairpin ribozyme by including a RNA protein binding site in helix 4.
Claim 19
Independent Claim 32 words
A method for localizing an enzymatic RNA molecule in a hairpin motif by providing a RNA protein binding sequence in said enzymatic RNA molecule and binding said site with a localizing protein.
Claim 20
Independent Claim 32 words
A method for localizing an enzymatic RNA molecule in a hairpin motif by providing a RNA protein binding sequence in said enzymatic RNA molecule and binding said site with a localizing protein.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-09-01 2001-03-03 2001-09-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-09-01 2005-03-03 2005-09-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-09-01 2009-03-03 2009-09-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag